Cargando…
Retinal Vasculopathy in Alzheimer’s Disease
The retina has been increasingly investigated as a site of Alzheimer’s disease (AD) manifestation for over a decade. Early reports documented degeneration of retinal ganglion cells and their axonal projections. Our group provided the first evidence of the key pathological hallmarks of AD, amyloid β-...
Autores principales: | Shi, Haoshen, Koronyo, Yosef, Rentsendorj, Altan, Fuchs, Dieu-Trang, Sheyn, Julia, Black, Keith L., Mirzaei, Nazanin, Koronyo-Hamaoui, Maya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493243/ https://www.ncbi.nlm.nih.gov/pubmed/34630020 http://dx.doi.org/10.3389/fnins.2021.731614 |
Ejemplares similares
-
Alzheimer’s Retinopathy: Seeing Disease in the Eyes
por: Mirzaei, Nazanin, et al.
Publicado: (2020) -
Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease
por: Shi, Haoshen, et al.
Publicado: (2020) -
Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation
por: Kasindi, Arielle, et al.
Publicado: (2022) -
The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer’s-related disease and preserving cognition
por: Danziger, Ron, et al.
Publicado: (2023) -
Parallels between retinal and brain pathology and response to immunotherapy in old, late‐stage Alzheimer's disease mouse models
por: Doustar, Jonah, et al.
Publicado: (2020)